AQR Capital Management - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 147 filers reported holding TRANSLATE BIO INC in Q1 2021. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$1,499,000
-17.6%
54,424
-50.6%
0.00%0.0%
Q1 2021$1,819,000
+49.2%
110,281
+66.8%
0.00%
+50.0%
Q4 2020$1,219,000
+91.1%
66,134
+41.1%
0.00%
+100.0%
Q3 2020$638,000
+217.4%
46,884
+319.0%
0.00%
Q2 2020$201,00011,1890.00%
Other shareholders
TRANSLATE BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,922,008$31,925,00048.23%
Omega Fund Management, LLC 2,437,603$19,842,0006.32%
FRAZIER MANAGEMENT LLC 2,182,789$17,768,0002.98%
Baupost Group 17,544,239$141,358,0001.56%
RTW INVESTMENTS, LP 3,304,808$26,901,0001.02%
Camber Capital Management LP 1,500,000$12,210,0000.62%
DAFNA Capital Management LLC 179,845$1,464,0000.50%
Bain Capital Public Equity Management II, LLC 416,670$3,392,0000.32%
Rock Springs Capital Management LP 950,000$7,733,0000.24%
Artal Group S.A. 650,000$5,291,0000.20%
View complete list of TRANSLATE BIO INC shareholders